Please Wait.....
Report
MEA Ophthalmology Market - Industry Trends and Forecast to 2030
Market Report I 2022-12-01 I 328 Pages I Data Bridge Market Research
The Middle East & Africa Ophthalmology market is projected to register a substantial CAGR of 4.6 % in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation
Middle East & Africa Ophthalmology Market, By Product Type (Device, Drugs, and Others), Diseases (Glaucoma, Cataract, Age-Related Macular Degeneration, Inflammatory Diseases, Refractive Disorders, and Others), Prescription Mode (Generic, and Branded), Drug Type (Prescription, and Over the Counter (OTC)), Route of Administration (Oral, Topical, Injectables, Local Ocular, and Others) End User (Hospitals, Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (South Africa, Saudi Arabia, UAE, Egypt, Israel, Kuwait, and Rest of Middle East and Africa), Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the Middle East & Africa Ophthalmology market are:
- Rising prevalence of ophthalmic disorders & ocular pains
- Increasing unhygienic & sedentary lifestyle
- The rise in traumatic injuries
- The rise in the geriatric population
Market Players
Some of the key market players for the Middle East & Africa Ophthalmology market are listed below:
- Johnson & Johnson Services, Inc.
- Novartis AG
- Bausch & Lomb Incorporated
- AbbVie Inc.
- Alcon
- Santen Pharmaceutical Co., Ltd.
- Others
TABLE OF CONTENTS
1 INTRODUCTION 83
1.1 OBJECTIVES OF THE STUDY 83
1.2 MARKET DEFINITION 83
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET 83
1.4 CURRENCY AND PRICING 85
1.5 LIMITATIONS 86
1.6 MARKETS COVERED 86
2 MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET: SEGMENTATION 92
2.1 MARKETS COVERED 92
2.2 GEOGRAPHICAL SCOPE 93
2.3 YEARS CONSIDERED FOR THE STUDY 94
2.4 DBMR TRIPOD DATA VALIDATION MODEL 95
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 98
2.6 MULTIVARIATE MODELLING 99
2.7 PRODUCT SEGMENT LIFELINE CURVE 99
2.8 DBMR MARKET POSITION GRID 100
2.9 VENDOR SHARE ANALYSIS 102
2.10 MARKET END USER COVERAGE GRID 103
2.11 SECONDARY SOURCES 104
3 EXECUTIVE SUMMARY 105
4 PREMIUM INSIGHTS 108
4.1 PESTEL ANALYSIS 109
4.2 PORTER'S FIVE FORCES 110
5 EPIDEMIOLOGY 111
6 STRATEGIC INITIATIVES 112
7 MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET, REGULATION 113
8 MARKET OVERVIEW 116
8.1 DRIVERS 118
8.1.1 RISING PREVALENCE OF OPHTHALMIC DISORDERS & OCULAR PAINS 118
8.1.2 INCREASING UNHYGIENIC & SEDENTARY LIFESTYLE 118
8.1.3 RISE IN TRAUMATIC INJURIES 119
8.1.4 RISE IN THE GERIATRIC POPULATION 119
8.2 RESTRAINTS 120
8.2.1 HIGH COST & RISKS ASSOCIATED WITH EYE SURGERY & TREATMENT 120
8.2.2 LACK OF HEALTH INSURANCE AMONGST THE POPULATION, ESPECIALLY WITHIN THE DEVELOPING COUNTRIES 120
8.2.3 SIDE EFFECTS ASSOCIATED WITH TREATMENT DRUGS 121
8.3 OPPORTUNITIES 122
8.3.1 RISE IN HEALTHCARE EXPENDITURE AND DISPOSABLE INCOME 122
8.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 122
8.3.3 RISING AWARENESS TO PREVENT THE BURDEN OF EYE DISEASES 123
8.4 CHALLENGE 124
8.4.1 LACK OF SKILLED PROFESSIONALS 124
8.4.2 STRINGENT RULES & REGULATIONS FOR PRODUCT APPROVAL 124
9 MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET, BY PRODUCTS 126
9.1 OVERVIEW 127
9.2 DEVICE 130
9.2.1 SURGICAL DEVICE 131
9.2.1.1 CATARACT SURGICAL DEVICES 131
9.2.1.2 OPHTHALMIC VISCOELASTIC DEVICES 131
9.2.1.2.1 PHACOEMULSIFICATION DEVICES 132
9.2.1.2.2 CATARACT SURGICAL LASERS 132
9.2.1.2.3 IOL INJECTORS 132
9.2.1.3 VITREORETINAL SURGICAL DEVICES 132
9.2.1.3.1 VITREORETINAL PACKS 132
9.2.1.3.2 VITRECTOMY MACHINES 132
9.2.1.3.3 VITRECTOMY PROBES 133
9.2.1.3.4 PHOTOCOAGULATION LASERS 133
9.2.1.3.5 ILLUMINATION DEVICES 133
9.2.1.4 REFRACTIVE SURGICAL DEVICES 133
9.2.1.4.1 FEMTOSECOND LASERS 133
9.2.1.4.2 EXCIMER LASERS 133
9.2.1.4.3 OTHER REFRACTIVE SURGICAL LASERS 133
9.2.1.5 GLAUCOMA SURGICAL DEVICES 134
9.2.1.5.1 GLAUCOMA DRAINAGE DEVICES 134
9.2.1.5.2 GLAUCOMA LASER SYSTEMS 134
9.2.1.5.3 MICRO INVASIVE GLAUCOMA SURGERY DEVICES 134
9.2.2 DIAGNOSTIC DEVICE 135
9.2.2.1 AUTOREFRACTORS & KERATOMETERS 135
9.2.2.2 TONOMETER 135
9.2.2.3 PHOROPTERS 136
9.2.2.4 RETINOSCOPES 136
9.2.2.5 OPHTHALMOSCOPES 136
9.2.2.6 PERIMETERS/VISUAL FIELD ANALYZERS 136
9.2.2.7 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 136
9.2.2.7.1 A- SCAN IMAGING SYSTEM 136
9.2.2.7.2 B-SCAN IMAGING SYSTEM 136
9.2.2.7.3 PACHYMETERS 137
9.2.2.7.4 ULTRASOUND BIOMICROSCOPES 137
9.2.2.8 LENSMETERS 137
9.2.2.9 CORNEAL TOPOGRAPHY SYSTEMS 137
9.2.2.10 OPTICAL COHERENCE TOMOGRAPHY SCANNERS 137
9.2.2.11 FUNDUS CAMERAS 137
9.2.2.12 OPTICAL BIOMETRY SYSTEMS 137
9.2.2.13 SPECULAR MICROSCOPES 137
9.2.2.14 WAVEFRONT ABERROMETERS 137
9.2.2.15 CHART PROJECTORS 137
9.2.2.16 SLIT LAMPS 137
9.2.3 OPHTHALMIC SURGICAL ACCESSORIES 138
9.2.3.1 SURGICAL INSTRUMENTS & KITS 138
9.2.3.2 OPHTHALMIC FORCEPS 138
9.2.3.3 OPHTHALMIC SPATULA 138
9.2.3.4 OPHTHALMIC TIPS AND HANDLES 138
9.2.3.5 OPHTHALMIC CANNULAS 138
9.2.3.6 OPHTHALMIC SCISSORS 139
9.2.3.7 OTHERS SURGICAL ACCESSORIES 139
9.2.4 OPHTHALMIC MICROSCOPES 139
9.3 DRUGS 139
9.3.1 ANTI-INFLAMMATION DRUGS 140
9.3.1.1 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS 140
9.3.1.2 STEROIDAL ANTI-INFLAMMATORY DRUGS 140
9.3.2 ALLERGIC CONJUNCTIVITIS 141
9.3.3 DRY EYE DRUGS 141
9.3.4 RETINAL DISORDER DRUGS 141
9.3.5 ANTI-GLAUCOMA DRUGS 141
9.3.5.1 MIOTICS 141
9.3.5.1.1 PILOCARPINE 142
9.3.5.1.2 ESERINE 142
9.3.5.2 BETA ADRENERGIC ANTAGONISTS 142
9.3.5.2.1 TIMOLAL MALEATE 142
9.3.5.2.2 BETAXOLOL 142
9.3.5.3 PROSTAGLANDIN ANALOGS 143
9.3.5.3.1 LATANOPROST 143
9.3.5.3.2 BIMATOPROST 143
9.3.5.3.3 TRAVOPROST 143
9.3.5.3.4 TAFLUPROST 143
9.3.5.3.5 LATANOPROSTENE 143
9.3.5.4 ALPHA ADRENERGIC AGONISTS 144
9.3.5.4.1 EPINEPHRINE 144
9.3.5.4.2 DEPIVEPRINE 144
9.3.5.5 ANTI-VEGF DRUGS 144
9.3.5.5.1 RANIBIZUMAB 144
9.3.5.5.2 BEVACIZUMAB 145
9.3.6 OTHERS 145
9.4 OTHERS 145
9.4.1 VISION CARE PRODUCTS 146
9.4.1.1 SPECTACLES 146
9.4.1.2 CONTACT LENSES 146
9.4.1.2.1 SOFT CONTACT LENSES 146
9.4.1.2.2 HYBRID CONTACT LENSES 147
9.4.1.2.3 RIGID GAS PERMEABLE LENSES 147
9.4.2 OTHERS 147
10 MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET, BY DISEASES 148
10.1 OVERVIEW 149
10.2 INFLAMMATORY DISEASES 152
10.3 CATARACT 153
10.4 REFRACTIVE DISORDERS 154
10.5 GLAUCOMA 155
10.6 AGE-RELATED MACULAR DEGENERATION 156
10.7 OTHERS 157
11 MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE 158
11.1 OVERVIEW 159
11.2 BRANDED 162
11.3 GENERIC 163
12 MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET, BY DRUG TYPE 164
12.1 OVERVIEW 165
12.2 OVER THE COUNTER 168
12.3 PRESCRIPTION 169
13 MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION 170
13.1 OVERVIEW 171
13.2 TOPICAL 174
13.2.1 EYE DROPS 175
13.2.2 EYE SOLUTION 175
13.2.3 CREAM & OINTMENTS 175
13.2.4 GEL 175
13.2.5 OTHERS 175
13.3 ORAL 175
13.3.1 TABLET 176
13.3.2 CAPSULES 176
13.3.3 OTHERS 176
13.4 LOCAL OCULAR 176
13.4.1 SUBCONJUNCTIVAL 177
13.4.2 INTRAVITREAL 177
13.4.3 RETROBULBAR 177
13.4.4 INTRACAMERAL 177
13.5 INJECTABLE 178
13.5.1 INTRAMUSCULAR 178
13.5.2 INTRAVENOUS 179
13.5.3 OTHERS 179
13.6 OTHERS 179
14 MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET, BY END USER 180
14.1 OVERVIEW 181
14.2 CLINICS 184
14.3 HOSPITALS 184
14.4 HOMECARE SETTINGS 185
14.5 OTHERS 186
15 MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL 187
15.1 OVERVIEW 188
15.2 RETAIL SALES 191
15.2.1 RETAIL SHOPS 191
15.2.2 HOSPITAL PHARMACY 192
15.2.3 ONLINE PHARMACY 192
15.3 DIRECT TENDER 192
15.4 OTHERS 193
16 MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET, BY GEOGRAPHY 194
16.1 MIDDLE EAST AND AFRICA 195
16.1.1 SOUTH AFRICA 211
16.1.2 SAUDI ARABIA 221
16.1.3 U.A.E. 231
16.1.4 EGYPT 241
16.1.5 KUWAIT 251
16.1.6 ISRAEL 261
16.1.7 REST OF MIDDLE EAST AND AFRICA 271
17 MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET: COMPANY LANDSCAPE 272
17.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 272
18 SWOT ANALYSIS 273
19 COMPANY PROFILE 274
19.1 ALCON 274
19.1.1 COMPANY SNAPSHOT 274
19.1.2 RECENT FINANCIALS 275
19.1.3 COMPANY SHARE ANALYSIS 275
19.1.4 PRODUCT PORTFOLIO 276
19.1.5 RECENT DEVELOPMENTS 276
19.2 REGENERON PHARMACEUTICALS INC. 278
19.2.1 COMPANY SNAPSHOT 278
19.2.2 RECENT FINANCIALS 278
19.2.3 COMPANY SHARE ANALYSIS 279
19.2.4 PRODUCT PORTFOLIO 279
19.2.5 RECENT DEVELOPMENT 279
19.3 JOHNSON & JOHNSON SERVICES, INC. 280
19.3.1 COMPANY SNAPSHOT 280
19.3.2 RECENT FINANCIALS 280
19.3.3 COMPANY SHARE ANALYSIS 281
19.3.4 PRODUCT PORTFOLIO 281
19.3.5 RECENT DEVELOPMENT 281
19.4 REICHERT, INC. 282
19.4.1 COMPANY SNAPSHOT 282
19.4.2 COMPANY SHARE ANALYSIS 282
19.4.3 PRODUCT PORTFOLIO 283
19.4.4 RECENT DEVELOPMENT 283
19.5 NOVARTIS AG 284
19.5.1 COMPANY SNAPSHOT 284
19.5.2 REVENUE ANALYSIS 284
19.5.3 COMPANY SHARE ANALYSIS 285
19.5.4 PRODUCT PORTFOLIO 285
19.5.5 RECENT DEVELOPMENTS 285
19.6 ABBVIE INC. 286
19.6.1 COMPANY SNAPSHOT 286
19.6.2 RECENT FINANCIALS 286
19.6.3 PRODUCT PORTFOLIO 287
19.6.4 RECENT DEVELOPMENT 287
19.7 BAUSCH & LOMB INCORPORATED 288
19.7.1 COMPANY SNAPSHOT 288
19.7.2 REVENUE ANALYSIS 288
19.7.3 PRODUCT PORTFOLIO 289
19.7.4 RECENT DEVELOPMENTS 289
19.8 CARL ZEISS MEDITEC AG 291
19.8.1 COMPANY SNAPSHOT 291
19.8.2 REVENUE ANALYSIS 291
19.8.3 PRODUCT PORTFOLIO 292
19.8.4 RECENT DEVELOPMENTS 292
19.9 ESSILORLUXOTTICA 293
19.9.1 COMPANY SNAPSHOT 293
19.9.2 REVENUE ANALYSIS 293
19.9.3 PRODUCT PORTFOLIO 294
19.9.4 RECENT DEVELOPMEN 294
19.10 F. HOFFMANN- LA ROCHE LTD 295
19.10.1 COMPANY SNAPSHOT 295
19.10.2 REVENUE ANALYSIS 295
19.10.3 PRODUCT PORTFOLIO 296
19.10.4 RECENT DEVELOPMENT 296
19.11 GLAUKOS 297
19.11.1 COMPANY SNAPSHOT 297
19.11.2 REVENUE ANALYSIS 297
19.11.3 PRODUCT PORTFOLIO 298
19.11.4 RECENT DEVELOPMENTS 298
19.12 HEIDELBERG ENGINEERING GMBH 299
19.12.1 COMPANY SNAPSHOT 299
19.12.2 PRODUCT PORTFOLIO 299
19.12.3 RECENT DEVELOPMENT 299
19.13 HOYA CORPORATION 300
19.13.1 COMPANY SNAPSHOT 300
19.13.2 REVENUE ANALYSIS 300
19.13.3 PRODUCT PORTFOLIO 301
19.13.4 RECENT DEVELOPMENTS 301
19.14 LUMENIS BE LTD. 302
19.14.1 COMPANY SNAPSHOT 302
19.14.2 PRODUCT PORTFOLIO 302
19.14.3 RECENT DEVELOPMENT 303
19.15 METALL ZUG AG 304
19.15.1 COMPANY SNAPSHOT 304
19.15.2 REVENUE ANALYSIS 304
19.15.3 PRODUCT PORTFOLIO 305
19.15.4 RECENT DEVELOPMENT 305
19.16 NEOVISION 306
19.16.1 COMPANY SNAPSHOT 306
19.16.2 PRODUCT PORTFOLIO 306
19.16.3 RECENT DEVELOPMENT 306
19.17 NIDEK CO., LTD. 307
19.17.1 COMPANY SNAPSHOT 307
19.17.2 PRODUCT PORTFOLIO 307
19.17.3 RECENT DEVELOPMENT 308
19.18 PFIZER INC. 309
19.18.1 COMPANY SNAPSHOT 309
19.18.2 REVENUE ANALYSIS 309
19.18.3 PRODUCT PORTFOLIO 310
19.18.4 RECENT DEVELOPMENT 310
19.19 SANTEN PHARMACEUTICAL CO., LTD. 311
19.19.1 COMPANY SNAPSHOT 311
19.19.2 RECENT FINANCIALS 311
19.19.3 PRODUCT PORTFOLIO 312
19.19.4 RECENT DEVELOPMENTS 312
19.20 SUN PHARMACEUTICAL INDUSTRIES LTD. 313
19.20.1 COMPANY SNAPSHOT 313
19.20.2 RECENT FINANCIALS 313
19.20.3 PRODUCT PORTFOLIO 314
19.20.4 RECENT DEVELOPMENTS 314
19.21 STAAR SURGICAL 315
19.21.1 COMPANY SNAPSHOT 315
19.21.2 REVENUE ANALYSIS 315
19.21.3 PRODUCT PORTFOLIO 316
19.21.4 RECENT DEVELOPMENTS 316
19.22 THE COOPER COMPANIES INC. 317
19.22.1 COMPANY SNAPSHOT 317
19.22.2 REVENUE ANALYSIS 317
19.22.3 PRODUCT PORTFOLIO 318
19.22.4 RECENT DEVELOPMENTS 318
19.23 TOPCON CORPORATION 319
19.23.1 COMPANY SNAPSHOT 319
19.23.2 REVENUE ANALYSIS 319
19.23.3 PRODUCT PORTFOLIO 320
19.23.4 RECENT DEVELOPMENTS 320
19.24 VISIONIX 321
19.24.1 COMPANY SNAPSHOT 321
19.24.2 PRODUCT PORTFOLIO 321
19.24.3 RECENT DEVELOPMENT 321
19.25 ZIEMER OPHTHALMIC SYSTEMS AG 322
19.25.1 COMPANY SNAPSHOT 322
19.25.2 PRODUCT PORTFOLIO 322
19.25.3 RECENT DEVELOPMENTS 323
20 QUESTIONNAIRE 324
21 RELATED REPORTS 328
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security